Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Korro Bio Inc (KRRO)

Korro Bio Inc (KRRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Korro Bio Inc 60 FIRST STREET 2ND FLOOR SUITE 250 CAMBRIDGE MA 02141 USA

www.korrobio.com Employees: 104 P: 617-468-1999

Sector:

Medical

Description:

Korro Bio Inc. is an RNA editing company focused on the discovery and development of a new class of precision genetic medicines for both rare and highly prevalent diseases. Korro Bio Inc., formerly known as Frequency Therapeutics Inc., is based in LEXINGTON, Mass.

Key Statistics

Overview:

Market Capitalization, $K 125,533
Enterprise Value, $K 69,893
Shares Outstanding, K 9,417
Float, K 8,984
% Float 95.40%
Short Interest, K 1,091
Short Float 11.58%
Days to Cover 6.11
Short Volume Ratio 0.38
% of Insider Shareholders 4.60%
% of Institutional Shareholders 13.18%

Financials:

Annual Sales, $ 2,270 K
Annual Net Income, $ -83,580 K
Last Quarter Sales, $ 1,090 K
Last Quarter Net Income, $ -18,060 K
EBIT, $ -96,770 K
EBITDA, $ -94,990 K

Growth:

1-Year Return -61.37%
3-Year Return -93.73%
5-Year Return -99.47%
5-Year Revenue Growth -92.16%
5-Year Earnings Growth 91.82%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.92 on 11/12/25
Next Earnings Date 03/17/26
Earnings Per Share ttm -9.41
EPS Growth vs. Prev Qtr 29.93%
EPS Growth vs. Prev Year 15.04%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 11/06/23

KRRO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -68.87%
Return-on-Assets % -45.91%
Profit Margin % -3,681.94%
Debt/Equity 0.00
Price/Sales 16.97
Price/Cash Flow N/A
Price/Book 1.26
Book Value/Share 10.55
Interest Coverage -1.73
60-Month Beta 2.95
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar